Eview article imiquimod applied topically a novel immune response modifier and new class of drug
Jump to navigation
Jump to search
Target Article[edit | edit source]
eview article imiquimod applied topically a novel immune response modifier and new class of drug; L Miller, JF Gerster, ML Owens, HB Sladeae; 1999; doi_citing_unknown
Retraction[edit | edit source]
Loss of (2'-5')oligoadenylate synthetase activity by production of antisense RNA results in lack of protection by interferon from viral infections ; Arrigo De Benedetti Barbara A Pytel Corrado Baglioni; 02/01/1987
- doi_cited_unknown
Citation piece[edit | edit source]
Note: Open to append information.